| Rezai, Ali |
NCT05603312: A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants |
|
|
| Completed | 1/2 | 14 | US | AAV-GAD Dose 1, AAV-GAD Dose 2, Sham Surgery | MeiraGTx, LLC | Parkinson Disease | 09/24 | 09/24 | | |
NCT05469009: Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy |
|
|
| Recruiting | 1 | 15 | US | Aducanumab, Aduhelm, Exablate Model 4000 Type 2, Focused Ultrasound, Lecanemab, Leqembi | Ali Rezai, InSightec | Mild Cognitive Impairment, Alzheimer Disease 1 | 07/29 | 07/29 | | |
DBS OUD, NCT03950492: Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder |
|
|
| Active, not recruiting | N/A | 4 | US | Deep Brain Simulator | West Virginia University, National Institute on Drug Abuse (NIDA), Medtronic | Opioid-Related Disorders | 12/22 | 12/26 | | |
NCT06612788: Exablate for LIFU Neuromodulation in Patients with Opioid Use Disorder (OUD) |
|
|
| Active, not recruiting | N/A | 5 | US | Exablate Model 4000 Type 2.0/2.1 | West Virginia University, National Institute on Drug Abuse (NIDA), InSightec | Opioid Use Disorder | 07/24 | 04/25 | | |
NCT04197921: Exablate for LIFU Neuromodulation in Patients with Opioid Use Disorder (OUD) And/or Other Substance Use Disorders (SUDs) |
|
|
| Recruiting | N/A | 29 | US | Exablate Model 4000 Type 2.0/2.1 | InSightec | Opioid-use Disorder, Substance Use Disorders | 12/25 | 12/26 | | |
NCT06218706: LIFU for Treatment for Refractory Opioid Use Disorder |
|
|
| Recruiting | N/A | 34 | US | Low Intensity Focussed Ultrasound | Ali Rezai, National Institute on Drug Abuse (NIDA) | Opioid Use Disorder | 10/26 | 03/28 | | |
NCT06485687: Low Intensity Focused Ultrasound for Binge Eating Disorder |
|
|
| Recruiting | N/A | 15 | US | LIFU Neuromodulation | Ali Rezai | Binge-Eating Disorder | 12/26 | 12/27 | | |
NCT03671889: ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease |
|
|
| Recruiting | N/A | 150 | US | Blood Brain Barrier (BBB) Disruption, ExAblate Neuro | InSightec | Alzheimer Disease | 12/25 | 12/25 | | |
NCT05997030: Low-Intensity Focused Ultrasound (LIFU) Neuromodulation |
|
|
| Recruiting | N/A | 15 | US | low intensity focused ultrasound (LIFU) | Ali Rezai | Alzheimer Disease | 09/25 | 09/25 | | |
NCT05976672: Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs |
|
|
| Recruiting | N/A | 500 | US | PRSS (Peer Recovery Support Specialist) | West Virginia University | Substance Abuse Disorder | 04/28 | 04/28 | | |
| Bockbrader, Marcia |
ETMS4Stress, NCT05835414: Electroencephalogram (EEG) Enhanced Transcranial Magnetic Stimulation (eTMS) for Chronic Trauma and Stressor-Related Disorders (TSRD) |
|
|
| Recruiting | 2/3 | 30 | US | Adjunctive, midline prefrontal, lower intensity, shorter session, EEG-enhanced, repetitive transcranial magnetic stimulation (eTMS) | Marcia Bockbrader, MD PhD, Ohio Department of Mental Health and Addiction Services | Trauma and Stressor Related Disorders | 06/24 | 06/25 | | |
